Advanced Search

 

Study ID Status Title Patient Level Data
30310/003 Completed A single centre randomised open non comparative study to assess the does response efficacy safety & tolerability of a single 200mg, 400mg or 600mg po dose of Oxibendazole in the treatment of intestinal helminth infections in adults
30310/004 Completed An open , non comparative study to assess the safety and efficacy , safety and tolerability of a single 400mg PO dose of oxibendazole in intestinal helminth infections in adults
30310/007 Completed A multicentre randomised parallel group study to assess the efficacy safety and tolerability of a single 400mg po dose of Oxibendazole suspension versus a single 500mg dose of Mebendazole tablet in the treatment of intestinal helminth infections in childre
30310/013 Completed A study to investigate the bioavailability of oxibendazole in healthy volunteers
3065A1-100 Completed Clinical trial to assess safety, tolerability and pharmacokinetics of orally administered Retigabine in healthy male volunteers
3065-A1-101 Completed Investigation into the tolerability, safety and steady state kinetics after repeated oral administration for 29 days of D-23129 in healthy volunteers
3065A1-102 Completed Ascending multiple dose tolerance study of retigabine in healthy male subjects
3065A1-103 Completed Relative Bioavailability of Retigabine (D-23129) from various modified release formulations (TESTS) versus immediate release capsule (REFERENCE) in healthy male volunteers
3065A1-104 Completed The effects of a high-fat meal on the pharmacokinetics of two sustained release formulations of retigabine (GKE-841;D-23129) in healthy male subjects
3065A1-105 Completed Effect of age and sex on the pharmacokinetics of retigabine
3065A1-106 Completed Food Interaction Study of Retigabine in Healthy Volunteers of Both Sexes
3065A1-107 Completed A 30-day safety and tolerability study of various titration regimens of retigabine in healthy male subjects
3065A1-108 Completed A study of the metabolic pathways and mass balance of orally administered [14C]-labeled Retigabine in healthy male subjects
3065A1-109 Completed An open-label, drug interaction study of retigabine and lamotrigine in healthy male subjects
3065A1-110 Completed A Comparative Bioavailability study of three oral dose formulations of retigabine in healthy adult subjects
3065A1-112 Completed A study of the potential effect of retigabine on the pharmacokinetics of an oral contraceptive containing norgestral and ethinyl estradiol in healthy female subjects
3065A1-113 Completed An open label drug interaction study of retigabine and Phenobarbital in healthy male subjects
3065A1-115 Completed Pharmacokinetics of Retigabine and its N-Acetylated Metabolite (NAMR) and the Impact on Serum Bilirubin in Subjects with Different Genotypes for UDP-glucuronyl transferase 1A1 (UGT1A1) and N-acetyl transferase (NAT2) Study Listed on ClinicalStudyDataRequest.com
3065A1-117 Completed Tolerability of intravenous dose titration of retigabine administered as short time infusion in healthy male volunteers Study Listed on ClinicalStudyDataRequest.com
3065A1-120 Completed Relative bioavailability of retigabine (D-23129) from various modified release formulations (TESTS) versus immediate release capsules (REFERENCE) in healthy male volunteers – second study
3065A1-121 Completed A study of the effects of blood collection processing on measured retigabine concentrations in healthy male volunteers
3065A1-123 Completed Absolute and Relative Bioavailability of Retigabine IR capsules in Healthy Male Subjects Study Listed on ClinicalStudyDataRequest.com
3065A1-200/201 Completed Efficacy, Tolerability, Safety and Pharmacokinetics of orally administered D-23129 in patients with partial onset seizures
3065A1-202 Completed A Multicenter, Open-Label, Safety, Tolerability, and Preliminary Efficacy Study of GKE-841 (Retigabine, D-23129) Administered as Add-On Therapy to Patients with Epilepsy Currently Receiving Monotherapy with an Established Anticonvulsive Agent
3065A1-205 Completed A Randomized, Double-blind, Placebo-controlled, Parallel group, Multicenter, Dose-ranging, Efficacy and Safety Study of Retigabine (D-23129; GKE-841) Administered as Add-on Therapy in Patients With Partial Epilepsy Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.